Monash University, Clayton, Victoria, Australia.
Shape Clinic, Darlinghurst, New South Wales, Australia.
Australas J Dermatol. 2020 Aug;61(3):217-225. doi: 10.1111/ajd.13273. Epub 2020 Mar 22.
Facial aesthetic treatment with injectable neuromodulators and hyaluronic acid fillers is well established, with favourable safety profiles and consistent outcomes. As with any medical treatment, adverse events and complications may occur. Adverse events associated with these products are typically transient and mild to moderate in severity. Serious adverse events, such as infection and intravascular occlusion, are rare. Proper patient selection, consent and counselling, preparation and impeccable injection technique are important risk reduction strategies. Both clinicians and patients must be alert to the signs and symptoms of complications so that appropriate treatment can be started promptly. In this article, the authors review the current literature and provide their consensus recommendations for minimising adverse outcomes when treating patients with botulinum toxin or hyaluronic acid fillers.
采用注射用神经调节剂和透明质酸填充物进行面部美学治疗已得到广泛认可，其具有良好的安全性和一致的治疗效果。与任何医疗治疗一样，可能会发生不良反应和并发症。与这些产品相关的不良反应通常是短暂的，且严重程度为轻度至中度。严重的不良反应（如感染和血管内闭塞）较为罕见。正确的患者选择、知情同意和咨询、准备工作以及完美的注射技术是重要的降低风险策略。临床医生和患者都必须警惕并发症的迹象和症状，以便能够及时开始进行适当的治疗。在本文中，作者回顾了当前的文献，并就如何使用肉毒毒素或透明质酸填充物治疗患者以最小化不良结果提供了共识建议。
